Kobayashi, H., et al. Hyperglycemia Regulated Circulating MicroRNAs and Their Effects on Renal Function Decline in Type 2 Diabetes. J Endocr Soc. 2021 May 3; 5(Suppl 1): A414. Published online 2021 May 3. doi: 10.1210/jendso/bvab048.845
Bhattacharya, A. et al. Distal mediator-enriched, placental transcriptome-wide analyses illustrate the Developmental Origins of Health and Disease. medRxiv APR 14, 2021. doi: https://doi.org/10.1101/2021.04.12.21255170. Pre-print
Pachynski, R. K., et al. Single cell spatial proteomic revelations on the multiparametric MRI heterogeneity of clinically significant prostate cancer. Clin Cancer Res March 26 2021 DOI: 10.1158/1078-0432.CCR-20-4217
Mens, M. et al. Circulatory MicroRNAs as Potential Biomarkers for Stroke Risk. Stroke. 2021 FEB 10 . https://doi.org/10.1161/STROKEAHA.120.031543
Guerrero-Zotano, A., et al. Plk1 expression & efficacy of Palbociclib in advanced hormonal receptor-positive breast cancer patients from PEARL study (GEICAM 2012-03). Cancer Res February 15 2021 (81) (4 Supplement) PS2-01; DOI: 10.1158/1538-7445.SABCS20-PS2-01
Bustos, M. A., et al. Identification of cell-free microRNA signatures in pre-operative plasma from breast cancer patients. Cancer Res February 15 2021 (81) (4 Supplement) PS2-17; DOI: 10.1158/1538-7445.SABCS20-PS2-17
Garcia-Flores, M., et al. Isolation and Characterization of Urine Microvesicles from Prostate Cancer Patients: Different Approaches, Different Visions. Research Square 2021 FEB DOI 10.21203/rs.3.rs-183251/v1. Preprint
Sinnberg, T., et al. IgA autoantibodies target pulmonary surfactant in patients with severe COVID-19. medRxiv preprint doi: https://doi.org/10.1101/2021.02.02.21250940 this version posted Feb 5, 2020.
Wu., J. et al. Biological Age in Healthy Elderly Predicts Dementia in the Absence of a Brain Marker. Research Square. DEC 11.2020 DOI: https://doi.org/10.21203/rs.3.rs-119310/v1. Preprint
Song, Y., et al. Tumor Microenvironment Associated with complete Response to Tislelizumab Monotherapy in Relapsed/Refractory Classical Hodgkin Lymphoma Reveals a Potentially Different Mechanism of Action. Blood Journal 2020. NOV 5 136(S1):10-11.
Davies, A., et al. Acalbrutinib in Combination with Rituximab, Cyclophosphamide, Doxorubicin, Vincristine and Prednisolone (R-CHOP) As First Line Therapy for Patients with Diffuse Large B-Cell Lymphoma (DLBCL): The Accept Phase lb/ll Single Arm Study. Blood Journal 2020 NOV 5 136 (S1):88-89.
Page last updated May 10, 2021